OUR SERVICES> TOXICOLOGY

General Toxicology (Acute to Chronic)
Pharmaseed toxicity-testing capabilities comprise a vast array of designs, ranging from acute single-dose studies to chronic studies, including specialty routes such as intra-cerebroventricular administration and infusion. All studies are fully GLP-certified and are in accordance with current guidelines, or custom-designed for particular needs.

Pharmaseed’s research facility includes a vivarium and supporting laboratory space of close to 750 square meters for use in general toxicology and biocompatibility studies on medical devices, pharmaceuticals and biotechnology-derived products.

Study Types

	Acute toxicology
	Sub-chronic toxicology
	Chronic toxicology
	Cytotoxicity
	Biocompatibility

Species

	Rodent
	Non-rodent

Treatments may be administered via the following routes:

Oral	Subcutaneous	Continuous Infusion (Alzet®)
Derma	Intracutaneous	Intratracheal
Intravenous	Intraperitoneal	Intrathecal

Our preclinical studies aim to support drug development as well as IND, IDE, NDA and PLA submissions. Pharmaseed has standard protocols for many studies, or can help you develop a custom protocol.

Pharmaseed’s experienced staff can work with you to design and execute cost-effective protocols for preclinical studies of medical devices, biotech-derived products and traditional pharmaceuticals.

All testing complies with applicable Good Laboratory Practice (GLP) regulations.